Evidence for secondary-variant genetic burden and non-random distribution across biological modules in a recessive ciliopathy

Maria Kousi, Onuralp Söylemez, Ayşegül Ozantürk, Sebastian Akle, Irwin Jungreis, Jean Muller, Christopher A. Cassa, Harrison Brand, Jill A. Rosenfeld, Maxim Y. Wolf, Azita Sadeghpour, Kelsey McFadden, Richard A. Lewis, Michael E. Talkowski, Hélène Dollfus, Manolis Kellis, Erica E. Davis, Shamil Sunyaev, Nicholas KatsanisbioRxiv 2018 · DOI

Abstract

The influence of genetic background on driver mutations is well established; however, the mechanisms by which the background interacts with Mendelian loci remains unclear. We performed a systematic secondary-variant burden analysis of two independent Bardet-Biedl syndrome (BBS) cohorts with known recessive biallelic pathogenic mutations in one of 17 BBS genes for each individual. We observed a significant enrichment of trans-acting rare nonsynonymous secondary variants compared to either population controls or to a cohort of individuals with a non-BBS diagnosis and recessive variants in the same gene set. Strikingly, we found a significant over-representation of secondary alleles in chaperonin-encoding genes, a finding corroborated by the observation of epistatic interactions involving this complex in vivo. These data indicate a complex genetic architecture for BBS that informs the biological properties of disease modules and presents a model paradigm for secondary-variant burden analysis in recessive disorders.

Introduction

In classical Mendelian genetics, recessive disorders are typically viewed through a "one-gene, two-hit" lens: the inheritance of two pathogenic alleles at a single locus results in a predictable clinical phenotype. However, clinical practice frequently reveals a more complex reality. Patients harboring identical "driver" mutations often exhibit significant variable expressivity—differences in the severity, onset, or specific symptoms of the disease. This suggests that the broader genetic background plays a critical role in modulating the primary mutation's effect.

Bardet-Biedl syndrome (BBS), a pleiotropic ciliopathy characterized by obesity, polydactyly, renal anomalies, and retinal degeneration, serves as an ideal model for studying this phenomenon. While BBS is primarily recessive, previous research has hinted at a "triallelic" or oligogenic inheritance pattern. This study provides a systematic analysis of the secondary-variant burden in BBS, demonstrating that clinical outcomes are shaped by a non-random accumulation of rare variants across specific biological modules.

Methodology and Cohort Design

To investigate the genetic background hypothesis, researchers conducted targeted exon capture and sequencing of 17 known BBS genes across two independent cohorts:

  1. Discovery Cohort: 102 families of Northern European ancestry with confirmed biallelic BBS mutations.
  2. Replication Cohort: 89 unrelated individuals of mixed ethnicity.

The study utilized a Combined Multivariate and Collapsing (CMC) test to compare the frequency of rare, nonsynonymous secondary variants (those occurring outside the primary disease-causing locus) between cases and controls. Controls included 384 Northern European individuals and 466 whole-exome sequenced individuals.

Crucially, the researchers included a "Non-BBS Recessive" cohort—50 individuals who carried biallelic mutations in BBS genes but were diagnosed with different clinical disorders (e.g., isolated retinitis pigmentosa). This group allowed the team to isolate the specific mutational signature that leads to a full BBS diagnosis.

The "Ultra-Rare" Signal and Modular Enrichment

The analysis revealed a significant enrichment of secondary variants in BBS patients, but only when focusing on "ultra-rare" alleles (Minor Allele Frequency < 0.001%). BBS patients showed a 2.3-fold to 2.5-fold enrichment of these variants compared to controls (p < 0.001). Approximately 22% of BBS patients carried at least one such additional variant.

Interestingly, these secondary mutations were not distributed randomly across the 17 genes. Instead, they were heavily concentrated within specific functional modules. The BBS proteome can be divided into the BBSome (a trafficking complex), the Transition Zone (a ciliary gatekeeper), and Chaperonins (protein folding chaperones). The study found a striking over-representation of secondary alleles in chaperonin-encoding genes, such as BBS10, BBS12, and MKKS.

Functional Validation via In Vivo Epistasis

To confirm that these statistical correlations reflected biological interactions, the researchers used zebrafish embryos to test for epistasis (gene-gene interactions). By suppressing pairs of BBS genes at sub-effective doses, they observed whether the combined phenotypic effect was additive or multiplicative.

The results were definitive: all six observed epistatic (multiplicative) interactions involved a chaperonin gene. This suggests that the chaperonin complex acts as a "vulnerable hub" within the BBS network. While interactions within a single complex (like the BBSome) tended to be additive, interactions between different modules (e.g., BBSome vs. Chaperonins) were more likely to be epistatic, pushing the organism toward a disease state.

The Threshold Model of Recessive Disease

The findings support a "threshold model" for BBS. The "non-BBS recessive" cohort not only lacked the secondary-variant burden but also possessed less disruptive primary mutations (higher BLOSUM scores) compared to the BBS cohort (p = 4 x 10^-5).

This suggests that a clinical diagnosis of BBS requires a cumulative mutational load. A patient must cross a biological threshold determined by the combination of:

  1. The severity of the primary "driver" mutations.
  2. The presence of ultra-rare secondary variants in interacting biological modules, particularly the chaperonin complex.

Conclusion and Future Directions

This study moves beyond agnostic genome-wide association studies, which often lack the power to detect signals in rare diseases. By treating sets of related genes as functional units, the researchers identified a systematic burden that explains variable expressivity in a Mendelian disorder.

The 22% prevalence of secondary variants is likely a conservative estimate, as the study was limited to 17 genes. Future research utilizing whole-genome sequencing will likely uncover additional burden in the broader "ciliome" and non-coding regions. This modular approach provides a roadmap for understanding the complex genetic architecture of other recessive disorders and improving the predictive power of clinical genomics.

Summary updated

Abstract

Abstract The influence of genetic background on driver mutations is well established; however, the mechanisms by which the background interacts with Mendelian loci remains unclear. We performed a systematic secondary-variant burden analysis of two independent Bardet-Biedl syndrome (BBS) cohorts with known recessive biallelic pathogenic mutations in one of 17 BBS genes for each individual. We observed a significant enrichment of trans -acting rare nonsynonymous secondary variants compared to either population controls or to a cohort of individuals with a non-BBS diagnosis and recessive variants in the same gene set. Strikingly, we found a significant over-representation of secondary alleles in chaperonin-encoding genes, a finding corroborated by the observation of epistatic interactions involving this complex in vivo . These data indicate a complex genetic architecture for BBS that informs the biological properties of disease modules and presents a model paradigm for secondary-variant burden analysis in recessive disorders.
BibTeX
@misc{kousi2018evidence,
  author = {Maria Kousi and Onuralp Söylemez and Ayşegül Ozantürk and Sebastian Akle and Irwin Jungreis and Jean Muller and Christopher A. Cassa and Harrison Brand and Jill A. Rosenfeld and Maxim Y. Wolf and Azita Sadeghpour and Kelsey McFadden and Richard A. Lewis and Michael E. Talkowski and Hélène Dollfus and Manolis Kellis and Erica E. Davis and Shamil Sunyaev and Nicholas Katsanis},
  title = {{Evidence for secondary-variant genetic burden and non-random distribution across biological modules in a recessive ciliopathy}},
  year = {2018},
  doi = {10.1101/362707},
  howpublished = {bioRxiv},
}
Figure